We advocate for compounding pharmacies and facilities on a range of state and federal issues affecting patient access to compounded medications. We represent pharmacists and technicians in both traditional 503A compounding pharmacies and 503B outsourcing facilities, as well as prescribers, patients, educators, and suppliers. We’re 5,000 members strong and growing.
We’ve had enough of drug manufacturers’ misrepresentation of pharmacy compounding. It's time to set the record straight.
When's the last time you checked out our federal and state advocacy pages?
The Bay State is considering a tax on pharmacies — and APC (and NCPA) are pushing back.
APC's Tenille Davis was at USP's meeting as a voting member.
APC submitted an amicus brief supporting an en banc motion by Wells Pharma, which is defending itself against a lawsuit by Zyla Life Sciences.
.png?width=410&height=320&name=image-container%20(1).png)
.png?width=410&height=320&name=image-container%20(2).png)
.png?width=411&height=320&name=image-container%20(3).png)
.png?width=410&height=320&name=image-container%20(4).png)
.png)
.png?width=17&height=16&name=folder%20(1).png){kind=small}
%20Pharma-GS.png)